DD298205A5 - Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen - Google Patents

Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen Download PDF

Info

Publication number
DD298205A5
DD298205A5 DD90344294A DD34429490A DD298205A5 DD 298205 A5 DD298205 A5 DD 298205A5 DD 90344294 A DD90344294 A DD 90344294A DD 34429490 A DD34429490 A DD 34429490A DD 298205 A5 DD298205 A5 DD 298205A5
Authority
DD
German Democratic Republic
Prior art keywords
drug
granules
long
copolymer
acting
Prior art date
Application number
DD90344294A
Other languages
German (de)
English (en)
Inventor
Tadayoshi Ohmura
Muneo Fukui
Hiroshi Sugiura
Satoru Yoneya
Toshiharu Hosono
Atsushi Kajiyama
Original Assignee
�������@�������������@��Kk���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@�������������@��Kk���Kk�� filed Critical �������@�������������@��Kk���Kk��
Publication of DD298205A5 publication Critical patent/DD298205A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
DD90344294A 1989-03-10 1990-03-12 Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen DD298205A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5868489 1989-03-10

Publications (1)

Publication Number Publication Date
DD298205A5 true DD298205A5 (de) 1992-02-13

Family

ID=13091382

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90344294A DD298205A5 (de) 1989-03-10 1990-03-12 Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DD90338614A DD292374A5 (de) 1989-03-10 1990-03-12 Verfahren zum herstellen von ueberzugsmaterialien zur steuerung der arzneimittelfreisetzung bei langzeitwirkenden zubereitungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90338614A DD292374A5 (de) 1989-03-10 1990-03-12 Verfahren zum herstellen von ueberzugsmaterialien zur steuerung der arzneimittelfreisetzung bei langzeitwirkenden zubereitungen

Country Status (19)

Country Link
US (1) US5028664A (ja)
EP (1) EP0386967B1 (ja)
JP (1) JPH037238A (ja)
KR (1) KR0140985B1 (ja)
CN (1) CN1045524A (ja)
AT (1) ATE124864T1 (ja)
AU (1) AU623233B2 (ja)
CA (1) CA2011919A1 (ja)
DD (2) DD298205A5 (ja)
DE (1) DE69020758T2 (ja)
DK (1) DK0386967T3 (ja)
ES (1) ES2077023T3 (ja)
FI (1) FI97690C (ja)
GR (1) GR3017645T3 (ja)
HU (1) HU204201B (ja)
IE (1) IE68520B1 (ja)
NO (1) NO301578B1 (ja)
NZ (1) NZ232836A (ja)
PT (1) PT93384B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
WO1995005168A1 (en) * 1993-08-19 1995-02-23 Shug Austin L Delayed release carnitine
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
NZ270078A (en) * 1994-12-06 1998-05-27 Bernard Charles Sherman Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
ES2199289T3 (es) * 1995-07-26 2004-02-16 Kyowa Hakko Kogyo Co., Ltd. Dispersion solida de derivados de xantina.
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
KR20010040819A (ko) 1998-02-10 2001-05-15 가마꾸라 아끼오 제어방출형 제제
ES2290027T3 (es) * 1999-05-20 2008-02-16 Elan Corporation, Plc Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
ATE376414T1 (de) * 1999-09-02 2007-11-15 Nostrum Pharmaceuticals Inc Pellet formulierung mit gesteuerter freisetzung
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
EP1454634A4 (en) * 2001-11-21 2007-05-30 Eisai R&D Man Co Ltd PREPARATIONS WITH SAVER ELABILES PHYSIOLOGICALLY ACTIVE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
CN100398122C (zh) * 2005-01-28 2008-07-02 北京北大药业有限公司 一种治疗颈、腰椎病中药的肠溶包衣组合物
BRPI0822140A8 (pt) 2008-01-10 2022-07-05 Evonik Roehm Gmbh Preparação farmacêutica ou nutracêutica revestida tendo liberação pulsada de subsatância ativa
CA2711475A1 (en) * 2008-01-10 2009-07-16 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
EP3695835A1 (en) 2009-02-03 2020-08-19 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
JP2021533194A (ja) 2018-07-31 2021-12-02 マイクロビオン コーポレーション ビスマス・チオール組成物及び創傷を治療する方法
KR20210084425A (ko) 2018-07-31 2021-07-07 마이크로비온 코포레이션 비스무트-티올 조성물 및 사용 방법
WO2022029938A1 (ja) * 2020-08-05 2022-02-10 マルホ株式会社 皮膚用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236914A (en) * 1959-05-12 1966-02-22 Canadian Ind Method for rendering polymers compatible
US3300429A (en) * 1963-06-17 1967-01-24 Rohm & Haas Aqueous polymeric blends containing ureido monomer
US3369009A (en) * 1964-12-10 1968-02-13 Hercules Inc Azidoformate-containing copolymers
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US4065523A (en) * 1975-11-24 1977-12-27 Rohm And Haas Company Process for increasing molecular weight of a polymer
US4082705A (en) * 1976-02-05 1978-04-04 Johnson & Johnson Pressure sensitive adhesive compositions
GB2046275A (en) * 1979-03-27 1980-11-12 American Cyanamid Co Granulation and drying aids for polymeric gels
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
JPS60240747A (ja) * 1984-05-15 1985-11-29 Showa Denko Kk 架橋性組成物及びエステル架橋型重合体
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JP2667162B2 (ja) * 1986-11-04 1997-10-27 日本製紙株式会社 インクジエツト記録用シート
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat

Also Published As

Publication number Publication date
PT93384B (pt) 1996-03-29
DD292374A5 (de) 1991-08-01
KR0140985B1 (ko) 1998-06-01
EP0386967A2 (en) 1990-09-12
AU5122790A (en) 1990-09-13
EP0386967B1 (en) 1995-07-12
ES2077023T3 (es) 1995-11-16
NO901116D0 (no) 1990-03-09
EP0386967A3 (en) 1991-04-03
HU204201B (en) 1991-12-30
NO301578B1 (no) 1997-11-17
US5028664A (en) 1991-07-02
NZ232836A (en) 1991-06-25
IE68520B1 (en) 1996-06-26
CN1045524A (zh) 1990-09-26
FI97690C (fi) 1997-02-10
JPH037238A (ja) 1991-01-14
GR3017645T3 (en) 1996-01-31
DK0386967T3 (da) 1995-11-20
FI97690B (fi) 1996-10-31
ATE124864T1 (de) 1995-07-15
HUT53813A (en) 1990-12-28
PT93384A (pt) 1990-11-07
KR900013943A (ko) 1990-10-22
AU623233B2 (en) 1992-05-07
DE69020758T2 (de) 1995-12-07
DE69020758D1 (de) 1995-08-17
CA2011919A1 (en) 1990-09-10
HU901380D0 (en) 1990-05-28
IE900862L (en) 1990-09-10
NO901116L (no) 1990-09-11
FI901195A0 (fi) 1990-03-09

Similar Documents

Publication Publication Date Title
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DE69230112T2 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE3751860T2 (de) Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung von Omeprazol sind
EP0519870B1 (de) Neue orale Diclofenaczubereitung
DE69518820T2 (de) Rotogranulat und Beschichtung von Acetaminophen, Pseudoephedrin, Chlorpheniramin und, gegebenenfalls, Dextromethorphan
DE69022876T2 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
DE69315257T2 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69111832T2 (de) Naproxen-Formulierung zur kontrollierten Absorption zur einmal täglichen Anwendung.
DE69629797T2 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
EP0068191B2 (de) Orale Dipyridamolformen
DE69917866T2 (de) Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
EP0348808B1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
DE69630286T2 (de) Aus mehreren einzeleinheiten zusammengesetzte dosierungsformen enthaltend einem protonen pumpen inhibitor
EP0934058B1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
AT396329B (de) Pharmazeutische granulate und verfahren zu ihrer herstellung
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
DE60108255T2 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
DD146547A5 (de) Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE602006000819T2 (de) Dipyridamol enthaltende Zusammensetzungen mit verlängerter Freisetzung und Verfahren zu deren Herstellung
EP0386440A1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DE69526467T2 (de) Arzneizubereitungen für die verlängerte Trimetazidinfreisetzung nach oraler Verabreichnung
DE3915150A1 (de) Lang-wirkende diclofenac-natrium-praeparation
EP1017392B1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DE69706969T2 (de) Metall valproat-tabletten mit verzoegerter freisetzung
DE3856555T2 (de) Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee